Stay updated on Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior Revision: v3.4.1 notice and government funding/operating status notices.
    Difference
    0.5%
    Check dated 2026-02-11T10:57:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice and the current revision tag v3.4.1 were added, and the previous revision tag v3.4.0 was removed.
    Difference
    0.5%
    Check dated 2026-02-04T10:26:19.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor UI and footer text updates were made: added 'Show glossary', corrected capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision version to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:18:09.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor release-note update: the page now shows Revision: v3.3.4 and Revision: v3.3.3 has been removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:16.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:33:23.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.2.0 to v3.3.2; this change does not affect the study details, eligibility criteria, outcomes, or any content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:50:00.000Z thumbnail image

Stay in the know with updates to Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Platinum Recurrent Germ Cell Tumors Clinical Trial page.